Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Emergent BioSolutions Inc. | 11,296 | reported | 30 Apr 2026 | tx 144+506,208−325,821 |
| Aptevo Therapeutics Inc. | 7,200 | reported | 06 Aug 2025 | tx 29+159,406−8,271 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Apr 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 25,344 | 0.00 USD | |
| 30 Apr 2026 | GRANT_AWARD | Emergent BioSolutions Inc. | 11,296 | 0.00 USD | deriv |
| 06 Aug 2025 | GRANT_AWARD | Aptevo Therapeutics Inc. | 7,200 | 0.00 USD | deriv |
| 17 Jul 2025 | EXERCISE | Aptevo Therapeutics Inc. | 1 | — | |
| 17 Jul 2025 | EXERCISE | Aptevo Therapeutics Inc. | 1 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 34,403 | 0.00 USD | |
| 30 Apr 2025 | GRANT_AWARD | Emergent BioSolutions Inc. | 15,824 | 0.00 USD | deriv |
| 17 Jul 2024 | GRANT_AWARD | Aptevo Therapeutics Inc. | 925 | 0.00 USD | deriv |
| 02 Jun 2024 | EXERCISE | Aptevo Therapeutics Inc. | 81 | — | |
| 01 Jun 2024 | EXERCISE | Aptevo Therapeutics Inc. | 7 | — | |
| 01 Jun 2024 | EXERCISE | Aptevo Therapeutics Inc. | 7 | 0.00 USD | deriv |
| 02 Jun 2024 | EXERCISE | Aptevo Therapeutics Inc. | 81 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 17,430 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Emergent BioSolutions Inc. | 25,748 | 0.00 USD | deriv |
| 09 Aug 2023 | EXERCISE | Aptevo Therapeutics Inc. | 3,571 | — | |
| 09 Aug 2023 | EXERCISE | Aptevo Therapeutics Inc. | 3,571 | 0.00 USD | deriv |
| 01 Jun 2023 | EXERCISE | Aptevo Therapeutics Inc. | 297 | — | |
| 02 Jun 2023 | GRANT_AWARD | Aptevo Therapeutics Inc. | 3,571 | 0.00 USD | deriv |
| 01 Jun 2023 | EXERCISE | Aptevo Therapeutics Inc. | 297 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Emergent BioSolutions Inc. | 33,847 | 0.00 USD | |
| 09 Aug 2022 | GRANT_AWARD | Aptevo Therapeutics Inc. | 3,571 | 0.00 USD | deriv |
| 01 Jun 2022 | EXERCISE | Aptevo Therapeutics Inc. | 298 | — | |
| 01 Jun 2022 | EXERCISE | Aptevo Therapeutics Inc. | 298 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Emergent BioSolutions Inc. | 8,446 | 0.00 USD | |
| 01 Jun 2021 | GRANT_AWARD | Aptevo Therapeutics Inc. | 893 | 0.00 USD | deriv |